Ceftafit-TZ 1.125 Injection
Marketer
Medizia Biotech
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Ceftafit-TZ 1.125 Injection
Ceftafit-TZ 1.125 Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection progression. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is crucial; complete the entire treatment course, regardless of symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Ceftafit-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Ceftafit-TZ 1.125 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Ceftafit-TZ 1.125 Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Ceftafit-TZ 1.125 Injection:
Administering this medication will be handled by your physician or their assigned nurse; self-medication is strictly prohibited.
How Ceftafit-TZ 1.125 Injection works:
Ceftazidime/Tazobactam 1.125 g injection unites two active agents to combat bacterial infections. Ceftazidime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Tazobactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using Ceftafit-TZ 1.125 Injection concurrently with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftafit-TZ 1.125 is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Ceftafit-TZ 1.125 Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Ceftafit-TZ 1.125 Injection can induce drowsiness, blurred vision, and dizziness. Driving is prohibited should these effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Ceftafit-TZ 1.125 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with significant hepatic impairment should use Ceftafit-TZ 1.125 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Ceftafit-TZ 1.125 Injection :
Should you forget a scheduled Ceftafit-TZ 1.125 Injection, seek your physician's advice.
Facts to Know About Ceftafit-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently